{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:49:38Z","timestamp":1782370178229,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u201cClinical Medicine + X\u201d Research Project of the Affiliated Hospital of Qingdao University","award":["Grant NO. QDFY+X202101021"],"award-info":[{"award-number":["Grant NO. QDFY+X202101021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16192-y","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:03:59Z","timestamp":1779177839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Habitat analysis and other AI technologies for Ki-67 prediction in hepatocellular carcinoma: a multi-center study"],"prefix":"10.1186","volume":"26","author":[{"given":"Min","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongfeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"6","key":"16192_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"16192_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.21037\/hbsn-20-480","volume":"9","author":"DY Xie","year":"2020","unstructured":"Xie DY, Ren ZG, Zhou J, Fan J. GAO Q. (2020) 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2020;9(4): 452\u2013463.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"10127","key":"16192_CR3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. (2018) Hepatocellular carcinoma. Lancet. 2018; 391(10127):1301\u20131314.","journal-title":"Lancet"},{"issue":"12","key":"16192_CR4","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.annonc.2021.09.015","volume":"32","author":"N Harbeck","year":"2021","unstructured":"Harbeck N, Rastogi P, Martin M, et al. (2021) Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study. Ann Oncol. 2021;32(12):1571\u201381.","journal-title":"Ann Oncol"},{"key":"16192_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.lungcan.2021.02.009","volume":"154","author":"Z Li","year":"2021","unstructured":"Li Z, Li F, Pan C, et al. (2021) Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma. Lung Cancer. 2021;154:69\u201375.","journal-title":"Lung Cancer"},{"issue":"2","key":"16192_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.14740\/wjon1751","volume":"15","author":"V Ramos-Santillan","year":"2024","unstructured":"Ramos-Santillan V, Oshi M, Nelson E, Endo I, Takabe K. (2024) High Ki67 Gene Expression Is Associated With Aggressive Phenotype in Hepatocellular Carcinoma. World J Oncol. 2024;15(2):257\u201367.","journal-title":"World J Oncol"},{"key":"16192_CR7","doi-asserted-by":"crossref","unstructured":"Zhang X, Wu Z, Peng Y, et al. (2021) Correlationship between Ki67, VEGF, and p53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. Biomed Res Int(2025). 2021. Accessed 19 Aug 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/33954191\/","DOI":"10.1155\/2021\/6651397"},{"issue":"8","key":"16192_CR8","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11547-024-01853-4","volume":"129","author":"V Nardone","year":"2024","unstructured":"Nardone V, Reginelli A, Rubini D, et al. (2024) Delta radiomics: an updated systematic review. Radiol Med. 2024;129(8):1197\u2013214.","journal-title":"Radiol Med"},{"issue":"5","key":"16192_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.21147\/j.issn.1000-9604.2019.05.10","volume":"31","author":"Z Ye","year":"2019","unstructured":"Ye Z, Jiang H, Chen J, et al. (2019) Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study. Chin J Cancer Res. 2019;31(5):806\u201317.","journal-title":"Chin J Cancer Res"},{"key":"16192_CR10","doi-asserted-by":"crossref","unstructured":"Fan Y, Yu Y, Wang X, Hu M, Hu C. (2021) Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma. BMC Med Imaging(2025). 2021. https:\/\/pubmed.ncbi.nlm.nih.gov\/34130644\/. Accessed 22 Aug 2025.","DOI":"10.21203\/rs.3.rs-89492\/v1"},{"key":"16192_CR11","doi-asserted-by":"crossref","unstructured":"Cai C, Wang L, Tao L, et al. (2025) Imaging-Based Prediction of Ki-67 Expression in Hepatocellular Carcinoma: A Retrospective Study. Cancer Med(2025). 2025. Accessed 23 Aug 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/39964132\/","DOI":"10.1002\/cam4.70562"},{"key":"16192_CR12","doi-asserted-by":"crossref","unstructured":"Zhao YM, Xie SS, Wang J, et al. (2023) Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma. BMC Med Imaging(2025). 2023. Accessed 28 Aug 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/37737166\/","DOI":"10.1186\/s12880-023-01069-4"},{"key":"16192_CR13","doi-asserted-by":"crossref","unstructured":"Zhou L, Chen Y, Li Y, Wu C, Xue C, Wang X. (2023) Diagnostic value of radiomics in predicting Ki-67 and cytokeratin 19 expression in hepatocellular carcinoma: a systematic review and meta-analysis. Front Oncol(2025). 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/38234405\/. Accessed 25 Aug 2025.","DOI":"10.3389\/fonc.2023.1323534"},{"issue":"5","key":"16192_CR14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00261-024-04191-1","volume":"49","author":"D Zhang","year":"2024","unstructured":"Zhang D, Zhang XY, Lu WW, et al. (2024) Predicting Ki-67 expression in hepatocellular carcinoma: nomogram based on clinical factors and contrast-enhanced ultrasound radiomics signatures. Abdom Radiol (NY). 2024;49(5):1419\u201331.","journal-title":"Abdom Radiol (NY)"},{"key":"16192_CR15","unstructured":"Gul S, KhaN MS, Bibi A, Khandakar A, Ayari MA, Chowdhury MEH. (2022) Deep learning techniques for liver and liver tumor segmentation: A review. Comput Biol Med(2025). 2022. https:\/\/pubmed.ncbi.nlm.nih.gov\/35667155\/. Accessed 24 Aug 2025."},{"key":"16192_CR16","unstructured":"Tran KA, Kondrashova O, Bradley A, Williams ED, Pearson JV, Waddell N. (2021) Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med(2025). 2021. https:\/\/pubmed.ncbi.nlm.nih.gov\/34579788\/. Accessed 27 Aug 2025."},{"key":"16192_CR17","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.2147\/CMAR.S299020","volume":"13","author":"T Lin","year":"2021","unstructured":"Lin T, Mai J, Yan M, Li Z, Quan X, Chen X. (2021) A Nomogram Based on CT Deep Learning Signature: A Potential Tool for the Prediction of Overall Survival in Resected Non-Small Cell Lung Cancer Patients. Cancer Manag Res. 2021;13:2897\u2013906.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"16192_CR18","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/jmri.28982","volume":"59","author":"T Xia","year":"2024","unstructured":"Xia T, Zhao B, Li B, et al. (2024) MRI-Based Radiomics and Deep Learning in Biological Characteristics and Prognosis of Hepatocellular Carcinoma: Opportunities and Challenges. J Magn Reson Imaging. 2024;59(3):767\u201383.","journal-title":"J Magn Reson Imaging"},{"issue":"24","key":"16192_CR19","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1002\/cncr.31630","volume":"124","author":"S Napel","year":"2018","unstructured":"Napel S, Mu W, Jardim-Perassi BV, Aerts H, Gillies RJ. (2018) Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats. Cancer. 2018;124(24):4633\u201349.","journal-title":"Cancer"},{"issue":"15","key":"16192_CR20","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1158\/0008-5472.CAN-19-0213","volume":"79","author":"BV jardim-perassi","year":"2019","unstructured":"Iardim-Perassi BV, Huang S, Dominguez-Viqueira W, et al. (2019) Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models. Cancer Res. 2019;79(15):3952\u201364.","journal-title":"Cancer Res"},{"issue":"3","key":"16192_CR21","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/jmri.29523","volume":"61","author":"C Wang","year":"2025","unstructured":"Wang C, Wu F, Wang F, et al. (2025) The Association Between Tumor Radiomic Analysis and Peritumor Habitat-Derived Radiomic Analysis on Gadoxetate Disodium-Enhanced MRI With Microvascular Invasion in Hepatocellular Carcinoma. J Magn Reson Imaging. 2025;61(3):1428\u201339.","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"16192_CR22","doi-asserted-by":"publisher","first-page":"8615","DOI":"10.1007\/s00330-021-07941-7","volume":"31","author":"M Tang","year":"2021","unstructured":"Tang M, Zhou Q, Huang M, et al. (2021) Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI. Eur Radiol. 2021;31(11):8615\u201327.","journal-title":"Eur Radiol"},{"issue":"1","key":"16192_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2463\/mrms.rev.2021-0031","volume":"21","author":"T Murakami","year":"2022","unstructured":"Murakami T, Sofue K, Hori M. (2022) Diagnosis of Hepatocellular Carcinoma Using Gd-EOB-DTPA MR Imaging. Magn Reson Med Sci. 2022;21(1):168\u201381.","journal-title":"Magn Reson Med Sci"},{"issue":"7","key":"16192_CR24","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1007\/s00330-023-09419-0","volume":"33","author":"M Yan","year":"2023","unstructured":"Yan M, Zhang X, Zhang B, et al. Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy. Eur Radiol. 2023;33(7):4949\u201361.","journal-title":"Eur Radiol"},{"key":"16192_CR25","doi-asserted-by":"crossref","unstructured":"Yang F, Wan Y, Xu L, et al. (2021) MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study. Front Oncol(2025). 2021. Accessed 18 Aug 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/34476208\/","DOI":"10.3389\/fonc.2021.672126"},{"key":"16192_CR26","unstructured":"Wu H, Han X, Wang Z, et al. (2020) Prediction of the Ki-67 marker index in hepatocellular carcinoma based on CT radiomics features. Phys Med Biol(2025). 2020. Accessed 21 Aug 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/32756021\/"},{"key":"16192_CR27","doi-asserted-by":"crossref","unstructured":"Dong Y, Zuo D, Qiu YJ, Cao JY, Wang HZ, Wang WP. (2022) Prediction of Histological Grades and Ki-67 Expression of Hepatocellular Carcinoma Based on Sonazoid Contrast Enhanced Ultrasound Radiomics Signatures. Diagnostics (Basel) (2025). 2022. https:\/\/pubmed.ncbi.nlm.nih.gov\/36140576\/. Accessed 21 Aug 2025.","DOI":"10.3390\/diagnostics12092175"},{"key":"16192_CR28","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/JHC.S417123","volume":"10","author":"X Wang","year":"2023","unstructured":"Wang X, Zhao M, Zhang C, et al. (2023) Establishment and Clinical Application of the Nomogram Related to Risk or Prognosis of Hepatocellular Carcinoma: A Review. J Hepatocell Carcinoma. 2023;10:1389\u201398.","journal-title":"J Hepatocell Carcinoma"},{"key":"16192_CR29","doi-asserted-by":"publisher","first-page":"1134646","DOI":"10.3389\/fonc.2023.1134646","volume":"13","author":"G Qiu","year":"2023","unstructured":"Qiu G, Chen J, Liao W, Liu Y, Wen Z, Zhao Y. (2023) Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma. Front Oncol. 2023;13:1134646.","journal-title":"Front Oncol"},{"key":"16192_CR30","doi-asserted-by":"crossref","unstructured":"Liu Z, Yang S, Chen X, et al. (2022) Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping. Front Oncol(2025). 2022. Accessed 21 Aug 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/36313692\/","DOI":"10.3389\/fonc.2022.954445"},{"key":"16192_CR31","doi-asserted-by":"crossref","unstructured":"Li H, Zhang J, Liu B, Zheng Z, Xu Y. (2025) Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma. Front Oncol(2025). 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/40134596\/. Accessed 24 Aug 2025.","DOI":"10.3389\/fonc.2025.1531236"},{"issue":"3","key":"16192_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.acra.2023.07.019","volume":"31","author":"Y Yan","year":"2024","unstructured":"Yan Y, Lin XS, Ming WZ, et al. (2024) Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma. Acad Radiol. 2024;31(3):859\u201369.","journal-title":"Acad Radiol"},{"key":"16192_CR33","unstructured":"Liao H, Jiang H, Chen Y, et al. (2022) Predicting Genomic Alterations of Phosphatidylinositol-3 Kinase Signaling in Hepatocellular Carcinoma: A Radiogenomics Study Based on Next-Generation Sequencing and Contrast-Enhanced CT. Ann Surg Oncol(2025). 2022. Accessed 19 Aug 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/35286532\/"},{"key":"16192_CR34","doi-asserted-by":"crossref","unstructured":"Zhu ZW, Wu J, Guo Y, et al. (2025) Prediction of Ki-67 expression in hepatocellular carcinoma with machine learning models based on intratumoral and peritumoral radiomic features. World J Gastrointest Oncol(2025). 2025. Accessed 19 Aug 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/40487953\/","DOI":"10.4251\/wjgo.v17.i5.104172"},{"issue":"2","key":"16192_CR35","first-page":"350","volume":"11","author":"HD Zhang","year":"2023","unstructured":"Zhang HD, Li XM, Zhang YH, et al. (2023) Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI. J Clin Transl Hepatol. 2023;11(2):350\u20139.","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"16192_CR36","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/liv.15870","volume":"44","author":"F Wang","year":"2024","unstructured":"Wang F, Zhan G, Chen QQ, et al. (2024) Multitask deep learning for prediction of microvascular invasion and recurrence-free survival in hepatocellular carcinoma based on MRI images. Liver Int. 2024;44(6):1351\u201362.","journal-title":"Liver Int"},{"issue":"3","key":"16192_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s12072-022-10321-y","volume":"16","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu Y, Zhang W, et al. (2022) Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study. Hepatol Int. 2022;16(3):577\u201389.","journal-title":"Hepatol Int"},{"issue":"4","key":"16192_CR38","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s00261-023-04141-3","volume":"49","author":"J Yang","year":"2024","unstructured":"Yang J, Dong X, Wang F, et al. (2024) A deep learning model based on MRI for prediction of vessels encapsulating tumour clusters and prognosis in hepatocellular carcinoma. Abdom Radiol (NY). 2024;49(4):1074\u201383.","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"16192_CR39","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/jmri.29207","volume":"60","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yang C, Qian X, Dai Y, Zeng M. (2024) Evaluate the Microvascular Invasion of Hepatocellular Carcinoma (\u2264\u20095 cm) and Recurrence Free Survival with Gadoxetate Disodium-Enhanced MRI-Based Habitat Imaging. J Magn Reson Imaging. 2024;60(4):1664\u201375.","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"16192_CR40","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1007\/s00330-023-10339-2","volume":"34","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen J, Yang C, Dai Y, Zeng M. (2024) Preoperative prediction of microvascular invasion in hepatocellular carcinoma using diffusion-weighted imaging-based habitat imaging. Eur Radiol. 2024;34(5):3215\u201325.","journal-title":"Eur Radiol"},{"issue":"12","key":"16192_CR41","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1016\/j.acra.2023.06.029","volume":"30","author":"X Chen","year":"2023","unstructured":"Chen X, Yu Q, Peng J, et al. (2023) A Combined Model Integrating Radiomics and Deep Learning Based on Contrast-Enhanced CT for Preoperative Staging of Laryngeal Carcinoma. Acad Radiol. 2023;30(12):3022\u201331.","journal-title":"Acad Radiol"},{"issue":"6","key":"16192_CR42","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.acra.2023.11.024","volume":"31","author":"HF Liu","year":"2024","unstructured":"Liu HF, Wang M, Lu YJ, et al. (2024) CEMRI-Based Quantification of Intratumoral Heterogeneity for Predicting Aggressive Characteristics of Hepatocellular Carcinoma Using Habitat Analysis: Comparison and Combination of Deep Learning. Acad Radiol. 2024;31(6):2346\u201355.","journal-title":"Acad Radiol"},{"issue":"6","key":"16192_CR43","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/jmri.26974","volume":"51","author":"Y Chen","year":"2020","unstructured":"Chen Y, Qin X, Long L, et al. (2020) Diagnostic Value of Gd-EOB-DTPA-Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma. J Magn Reson Imaging. 2020;51(6):1755\u201363.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"16192_CR44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jmri.25555","volume":"46","author":"XX Hu","year":"2017","unstructured":"Hu XX, Yang ZX, Liang HY, et al. (2017) Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index. J Magn Reson Imaging. 2017;46(2):383\u201392.","journal-title":"J Magn Reson Imaging"},{"key":"16192_CR45","unstructured":"Li Y, Chen J, Weng S, et al. Small hepatocellular carcinoma: using MRI to predict histological grade and Ki-67 expression (2019) Clin Radiol(2025). 2019. Accessed 21 Aug 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/31200932\/"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16192-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16192-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16192-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:25:28Z","timestamp":1782368728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16192-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16192"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16192-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. This study included retrospective data from two medical centers. It was approved by two ethics committees: (1) The Medical Ethics Committee of The Affiliated Hospital of Qingdao University (Approval No. QYFYWZLL30258), which operates at The Affiliated Hospital of Qingdao University. (2) The Medical Ethics Committee of The Affiliated Hospital of Qingdao University (Pingdu Campus), which operates at The Affiliated Hospital of Qingdao University (Pingdu Campus) (formerly Pingdu Central Hospital). The institutional review board approved this retrospective study, and informed consent was waived due to the study\u2019s retrospective nature. All authors have been informed and have given their consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"775"}}